Stock MADHAVBAUG VAIDYA SANE AYURVED LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Vaidya Sane Ayurved Laboratories Limited

Equities

MADHAVBAUG

INE0JR301013

Market Closed - NSE India S.E.
Other stock markets
 05:13:55 28/06/2024 pm IST 		5-day change 1st Jan Change
168 INR +5.00% Intraday chart for Vaidya Sane Ayurved Laboratories Limited +5.00% -20.60%
26/05 Vaidya Sane Ayurved Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
26/05 Vaidya Sane Ayurved Laboratories Limited Appoints Narendra Pawar as Chief Financial Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vaidya Sane Ayurved Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Vaidya Sane Ayurved Laboratories Limited Appoints Narendra Pawar as Chief Financial Officer
CI
Vaidya Sane Ayurved Laboratories Limited Announces Resignation of Abhishek Deshpande as Company Secretary & Compliance Officer, Effective June 1, 2024
CI
Vaidya Sane Ayurved Laboratories Limited Announces Resignation of Darshan Shah as Chief Financial Officer, effective May 15, 2024
CI
Vaidya Sane Ayurved Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Vaidya Sane Ayurved Laboratories Limited completed the acquisition of Dynamic Remedies Private Limited and UV Ayurgen Pharma Private Limited from Atul Bhide and Madhura Bhide.
CI
Vaidya Sane Ayurved Laboratories Limited executed a Share Purchase Agreement to acquire Dynamic Remedies Private Limited and UV Ayurgen Pharma Private Limited from Atul Bhide and Madhura Bhide for INR 50 million.
CI
5,639,250 Equity Shares of Vaidya Sane Ayurved Laboratories Limited are subject to a Lock-Up Agreement Ending on 15-MAR-2023.
CI
Vaidya Sane Ayurved Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Vaidya Sane Ayurved Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Vaidya Sane Ayurved Laboratories Limited has completed an IPO in the amount of INR 202.2976 million.
CI
Vaidya Sane Ayurved Laboratories Limited has filed an IPO in the amount of INR 202.2976 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MADHAVBAUG Stock
  4. News Vaidya Sane Ayurved Laboratories Limited